Filter posts

Why Biotech Food Labeling Is Met with Resistance

In recent weeks, there’s been a lot of new discussion around the biotech labeling debate.  …

Announcing the Buzz of BIO Winner for Pipelines of Promise!

We’re very pleased to announce the Buzz of BIO Winner for the 2012 contest of …

myBIO and One-on-One Partnering... What's the Difference?

This June, thousands will gather in the biotech hub of Boston! One of the things …

Biosimilars Ahead, Proceed with Caution

By Richard M. Dolinar, M.D., Chairman, Alliance for Safe Biologic Medicines In today’s budget-constrained world, …

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is …

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward is a public round-table event hosted …

Help Children and Adults with Brittle Bones During OI Awareness Week

By Stuart Tart, Director of Development, Osteogenesis Imperfecta Foundation Ten years ago, Greg and wife …

American Invents Act Strategies Highlighted at the IPCC Conference

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee …

World Congress Wraps Up With Session on Demand for Biotech Products

Throughout BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing various audiences were discussed …

BioManufacturers Increasing Budgets for New Technologies

By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost …